Sano V
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Sano V - overview
Established
2012
Location
Singapore, -, Singapore
Primary Industry
Medical Devices & Equipment
About
Based in Singapore, and founded in 2012, Sano V Pte. Ltd. operates as a medtech company that provides health care facilities for patients suffering from venogenic erectile dysfunction. In December 2020, Sano V Pte.
Ltd. raised USD1. 23 million in a series B funding round led by QT Vascular, a balloon catheter specialist. As of June 2022, the company is led by its CEO Eran Vickus.
Sano V Pte. Ltd. offerings include research and development of a men's health platform for the treatment of erectile dysfunction. The company treat the leak in venous leak ED.
Sano V Pte. Ltd. plans to use the series B funding for its first-in-man study and general working capital.
Primary Industry
Medical Devices & Equipment
Sub Industries
Medical Devices & Equipment, Pharmaceutical Research & Development
Website
www.sanovmed.com/
Verticals
HealthTech
Company Stage
Series B
Total Amount Raised
Subscriber access only
Sano V - financials
| Fiscal Year Ended | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | - | - | - | - | - | - | - | - | - | - |
| % Revenue Growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| EBITDA (USD) | (27,908.892) | (263,321.759) | (347,930.075) | (384,213.042) | (798,374.398) | (776,655.759) | (233,896.79) | - | - | - |
| Operating Income (USD) | (28,394.718) | (263,321.759) | (350,147.131) | (388,139.713) | (801,620.877) | (799,960.065) | (252,411.93) | - | - | - |
| Operating Margin | - | - | - | - | - | - | - | - | - | - |
| % EBITDA Margin | - | - | - | - | - | - | - | - | - | - |
| NET Income (USD) | (28,394.718) | (263,321.759) | (350,147.131) | (388,139.713) | (801,620.877) | (801,454.203) | (264,396.111) | - | - | - |
| % Net Margin | - | - | - | - | - | - | - | - | - | - |
Sano V - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series B | Completed | Sano V | - | ||||||||
| Series A | Completed | Sano V | - | ||||||||
| Seed | Completed | Sano V | - |
Displaying 1 - 3 of 3
Sano V - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.